APA

Zheng W., Yan F., Xue Q., Wu G., Qin W., Wang F., Qin J., Tian C. & Yuan J. (20150828). Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib. : OncoTargets and therapy.

Chicago

Zheng Wan-Xiang, Yan Fei, Xue Qin, Wu Guo-Jun, Qin Wei-Jun, Wang Fu-Li, Qin Jun, Tian Chun-Juan and Yuan Jian-Lin. 20150828. Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib. : OncoTargets and therapy.

Harvard

Zheng W., Yan F., Xue Q., Wu G., Qin W., Wang F., Qin J., Tian C. and Yuan J. (20150828). Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib. : OncoTargets and therapy.

MLA

Zheng Wan-Xiang, Yan Fei, Xue Qin, Wu Guo-Jun, Qin Wei-Jun, Wang Fu-Li, Qin Jun, Tian Chun-Juan and Yuan Jian-Lin. Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib. : OncoTargets and therapy. 20150828.